(Q37301555)

19 August 2017

1 reference

title

Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics (English)

1 reference

19 August 2017

1 reference

Page B Pennell

1

1 reference

19 August 2017

Collin A Hovinga

series ordinal

2

1 reference

19 August 2017

publication date

1 January 2008

1 reference

International Review of Neurobiology

19 August 2017

published in

1 reference

19 August 2017

volume

83

1 reference

19 August 2017

page(s)

227-240

1 reference

Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Serum phenytoin during pregnancy, labor and puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Oxcarbazepine concentrations during pregnancy: A retrospective study in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Pharmacokinetic considerations in prescribing antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Antiepileptic drugs and pregnancy: altered utilization patterns and teratogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Drug disposition and pharmacokinetics in the maternal-placental-fetal unit

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Pharmacokinetics of antiepileptic drugs during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Effects of pregnancy on antiepileptic drug utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Antiepileptic drug pharmacokinetics during pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

The impact of pregnancy and childbirth on the metabolism of lamotrigine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Plasma protein binding of drugs in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Individual changes in lamotrigine plasma concentrations during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Status epilepticus in pregnancy: Effect of phenytoin malabsorption on seizure control

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Teratogenic and pharmacokinetic studies of primidone during pregnancy and in the offspring of epileptic women

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Change of seizure frequency in pregnant epileptic women

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Disposition of carbamazepine and phenytoin in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Lamotrigine clearance during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Carbamazepine protein binding and disposition in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

Management issues for women with epilepsy: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2808%2900013-5

7 January 2021

10.1016/S0074-7742(08)00013-5

Identifiers

DOI

1 reference

19 August 2017

1 reference